Clinical Trial Update: Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of gamma-linolenic acid and thioctic acid in diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Gamma-linolenic acid (gamma-linolenic acid)
• thioctic acid (thioctic acid)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Diabetic Neuropathy | Phase 4 | Status: COMPLETED